Investigation Alerts for Multiple Company Mergers
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1d ago
0mins
Should l Buy CVGW?
Source: Globenewswire
- RAPT Acquisition Investigation: RAPT Therapeutics is set to be acquired by GlaxoSmithKline for $58 per share, totaling an estimated equity value of $2.2 billion, with investigations focusing on whether the board failed to conduct a fair process, potentially impacting shareholder rights.
- Calavo Merger Details: Calavo Growers will be acquired by Mission Produce, with shareholders receiving $27 per share, including $14.85 in cash and 0.9790 shares of Mission, valuing the transaction at approximately $430 million, while investigations examine if the board breached fiduciary duties to shareholders.
- Penumbra Acquisition Status: Penumbra will be acquired by Boston Scientific in a deal valuing the company at $374 per share, reflecting an enterprise value of about $14.5 billion, with investigations looking into whether the board ensured a fair process, potentially affecting shareholder interests.
- FONAR Merger Investigation: FONAR Corporation is to be acquired by FONAR, LLC for $19 per share in an all-cash transaction, with investigations questioning whether the board failed to conduct a fair process, which could impact shareholder rights.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CVGW?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CVGW
About CVGW
Calavo Growers, Inc. is a provider of value-added fresh food in the avocado industry. The Company is engaged in marketing and distributing avocados and prepared avocados to retail grocery, foodservice, club stores, mass merchandisers, food distributors and wholesalers on a worldwide basis. It procures avocados from California, Mexico and other growing regions around the world. Through its various operating facilities, it sorts, packs, and/or ripens avocados, tomatoes and/or Hawaiian grown papayas, and processes and packages guacamole. It operates in two business segments: Grown and Prepared. Its Grown segment consists of fresh avocados, tomatoes and papayas. Its Prepared segment comprises all its guacamole products sold at retail and food service as well as avocado pulp sold to foodservice. Its products are sold under the Calavo family of branded labels, as well as private labels. It distributes its products both domestically and internationally.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Legal Investigation Initiated: Halper Sadeh LLC is investigating RAPT Therapeutics, Inc. (NASDAQ: RAPT) regarding its sale to GSK plc for $58.00 per share, potentially violating fiduciary duties to shareholders and impacting shareholder rights.
- Shareholder Rights Protection: The transaction between Penumbra, Inc. (NYSE: PEN) and Boston Scientific Corporation involves $374.00 in cash or 3.8721 shares of Boston Scientific common stock per share, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures for shareholders.
- Cash and Stock Transaction: Calavo Growers, Inc. (NASDAQ: CVGW) is selling to Mission Produce, Inc. for $14.85 in cash and 0.9790 shares of Mission stock per share, prompting Halper Sadeh LLC to assess the potential impact of this transaction on shareholders.
- Management Transaction Review: FONAR Corporation (NASDAQ: FONR) is involved in a transaction with its CEO and certain executives for $19.00 per share for Class B common stock and $6.34 per share for Class C common stock, with Halper Sadeh LLC possibly advocating for enhanced shareholder rights.
See More
- RAPT Acquisition Investigation: RAPT Therapeutics is set to be acquired by GlaxoSmithKline for $58 per share, totaling an estimated equity value of $2.2 billion, with investigations focusing on whether the board failed to conduct a fair process, potentially impacting shareholder rights.
- Calavo Merger Details: Calavo Growers will be acquired by Mission Produce, with shareholders receiving $27 per share, including $14.85 in cash and 0.9790 shares of Mission, valuing the transaction at approximately $430 million, while investigations examine if the board breached fiduciary duties to shareholders.
- Penumbra Acquisition Status: Penumbra will be acquired by Boston Scientific in a deal valuing the company at $374 per share, reflecting an enterprise value of about $14.5 billion, with investigations looking into whether the board ensured a fair process, potentially affecting shareholder interests.
- FONAR Merger Investigation: FONAR Corporation is to be acquired by FONAR, LLC for $19 per share in an all-cash transaction, with investigations questioning whether the board failed to conduct a fair process, which could impact shareholder rights.
See More

- Merger Investigation: Halper Sadeh LLC is investigating Allegiant Travel Company's merger with Sun Country Airlines, where Allegiant shareholders are expected to own approximately 67% of the combined entity post-transaction, potentially impacting shareholder rights.
- Cash and Stock Deal: Sun Country Airlines is being sold to Allegiant for 0.1557 shares of Allegiant common stock and $4.10 in cash per share, raising concerns among shareholders regarding the fairness of the transaction structure.
- Calavo and Mission Merger: Calavo Growers, Inc. is being sold to Mission Produce, Inc. for $14.85 in cash and 0.9790 shares of Mission stock, with Mission shareholders expected to own about 80.3% of the combined company post-transaction, which may affect shareholder decision-making.
- Legal Rights Protection: Halper Sadeh LLC offers legal services on a contingency fee basis, encouraging shareholders to reach out to discuss their legal rights and options, demonstrating a commitment to protecting shareholder interests.
See More
- Dividend Yield Increase: United Breweries Co. (CCU) currently boasts a 2.8% dividend yield with a payout ratio of 58.9%, indicating sustainability and attractiveness in the beverage market, which has garnered investor interest.
- Stock Price Uptrend: CCU's stock price has risen over 11% at the start of the new year, forming a Golden Cross as the 50-day simple moving average crossed above the 200-day moving average, signaling a potential new bull market.
- Technical Indicator Confirmation: The MACD indicator shows a bullish crossover, indicating accumulating upward momentum, while the Relative Strength Index (RSI) has dipped below 70, suggesting potential for further price increases.
- International Diversification Investment: Cresud SACIF (CRESY), as a Latin American commodities producer, offers a dividend yield exceeding 5% and provides a solid investment diversification opportunity during geopolitical tensions, showcasing robust performance in agriculture and real estate.
See More
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating Calavo Growers, Inc. (NASDAQ:CVGW) regarding its sale to Mission Produce, Inc. for $14.85 in cash and 0.9790 shares, potentially violating fiduciary duties to shareholders.
- RAPT Transaction Review: The firm is also scrutinizing RAPT Therapeutics, Inc. (NASDAQ:RAPT) in its sale to GSK plc for $58.00 per share, aiming to ensure shareholders receive fair terms and necessary disclosures.
- Confluent Deal Assessment: For Confluent, Inc. (NASDAQ:CFLT) in its sale to IBM for $31.00 per share, Halper Sadeh LLC is evaluating the acquisition price and may seek increased compensation and other benefits for shareholders.
- Legal Service Commitment: Halper Sadeh LLC offers contingent fee legal services, encouraging shareholders to reach out to discuss their rights and options, demonstrating a strong commitment to protecting investor interests.
See More

- Shareholder Rights Protection: Monteverde & Associates is investigating the merger between Allegiant Travel and Sun Country Airlines, with Allegiant shareholders expected to own approximately 67% of the combined entity post-transaction, thereby enhancing their control in the aviation market.
- Cash and Stock Returns: Under the terms of the deal, Sun Country shareholders will receive 0.1557 shares of Allegiant common stock and $4.10 in cash per share, a structure designed to enhance shareholder value and attract more investor interest.
- Merger Transaction Impact: In the merger between Calavo Growers and Mission Produce, Calavo shareholders are expected to receive 0.9790 shares of Mission Produce common stock and $14.85 in cash per share, which will further consolidate market resources and enhance the competitive edge of both companies in the agricultural sector.
- Legal Service Commitment: Monteverde & Associates is renowned for its successful track record in securities class actions, emphasizing its commitment to advocating for shareholder rights, aiming to enhance client trust and satisfaction through professional legal services.
See More









